Furthermore, we performed a comprehensive analysis of the methylation status of the CYSLTR1 and CYSLTR2 genes, which serve as drivers for CRC prognosis and metastasis development and could be used as prognostic markers for CRC patients. Here, CYSLTR2 is linked to colorectal carcinoma.